mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |